GlassScriptPhysician profile
Michael Dean Marion
NPI 1942402433
$29,546.01
in general payments reported to CMS, 2019-2025
17 companies · $26K in 2025
The $26K reported for 2025 was more than what 97% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $378 · 2021: $384 · 2022: $687 · 2023: $277 · 2024: $1,327 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Travel and Lodging: $4,940 · Food and Beverage: $3,049 · Long Term Medical Supply Or Device Loan: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,023.33 |
| Travel and Lodging | $4,940.35 |
| Food and Beverage | $3,049.08 |
| Long Term Medical Supply Or Device Loan | $651.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15,958.09 | 2023-2025 | |
| Mentor Worldwide LLC | $10,957.40 | 2019-2025 | Mentor Cpx 2 Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $841.25 | 2019-2022 | |
| Integra Lifesciences Corporation | $715.35 | 2024 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Sientra, INC. | $323.80 | 2020-2022 | |
| Revance Therapeutics, INC. | $246.19 | 2024-2025 | Daxxify |
| Motiva USA, LLC | $155.28 | 2025 | |
| Galderma Laboratories, L.P. | $120.24 | 2019-2025 | |
| Medline Industries LP | $56.77 | 2022-2025 | |
| Tepha INC | $41.67 | 2019 | |
| Baudax Bio INC. | $33.56 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $25.45 | 2023 | Exparel |
| Apyx Medical Corporation | $23.08 | 2019 | |
| Medtronic, INC. | $16.70 | 2023 | Closurefast |
| Vertex Pharmaceuticals Incorporated | $16.53 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $14.65 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Marion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.